Prism Medico and Pharmacy Limited (BOM:512217)
India flag India · Delayed Price · Currency is INR
23.66
-1.04 (-4.21%)
At close: Mar 6, 2026

Prism Medico and Pharmacy Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Mar '25 Mar '24 Apr '23 Apr '22 Apr '21
Operating Revenue
22.356.3229.2512.7184.44167.64
Other Revenue
--0-0-
22.356.3229.2512.7184.44167.64
Revenue Growth (YoY)
217.22%-78.40%130.21%-84.95%-49.63%-37.66%
Cost of Revenue
13.654.4925.6111.4186.28166.68
Gross Profit
8.71.833.651.3-1.840.96
Selling, General & Admin
2.622.65.022.273.062.58
Other Operating Expenses
0.35-0.08-0.61-0.02--
Operating Expenses
2.992.564.462.323.152.7
Operating Income
5.71-0.73-0.82-1.02-4.99-1.75
Interest Expense
-0.03---0-0.01-
Interest & Investment Income
--0---
Currency Exchange Gain (Loss)
0.090.090.6---
Other Non Operating Income (Expenses)
-0.02-0.02-0.07-00-0
EBT Excluding Unusual Items
5.75-0.66-0.29-1.02-4.99-1.75
Pretax Income
5.75-0.66-0.28-1.02-4.99-1.75
Income Tax Expense
-0.26-0.17-0.07-0.26-1.29-0.45
Net Income
6.01-0.49-0.21-0.76-3.7-1.3
Net Income to Common
6.01-0.49-0.21-0.76-3.7-1.3
Shares Outstanding (Basic)
67066666
Shares Outstanding (Diluted)
67066666
Shares Change (YoY)
39.58%-3.31%-3.21%0.01%-
EPS (Basic)
0.01-0.08-0.04-0.13-0.61-0.21
EPS (Diluted)
0.01-0.08-0.04-0.13-0.61-0.21
Gross Margin
38.92%29.02%12.46%10.23%-2.18%0.57%
Operating Margin
25.53%-11.54%-2.80%-8.01%-5.90%-1.04%
Profit Margin
26.88%-7.71%-0.73%-6.00%-4.38%-0.78%
EBITDA
5.74-0.69-0.77-0.95-4.9-1.63
EBITDA Margin
25.68%-10.87%-2.61%-7.49%-5.80%-0.97%
D&A For EBITDA
0.030.040.050.070.090.12
EBIT
5.71-0.73-0.82-1.02-4.99-1.75
EBIT Margin
25.53%-11.54%-2.80%-8.01%-5.90%-1.04%
Revenue as Reported
22.76.4830.4812.7284.44167.64
Advertising Expenses
-0.170.34---
Source: S&P Global Market Intelligence. Standard template. Financial Sources.